DNA Methultransferases – Implications to Epigenetic Regulation and Cancer Therapy Targeting: James Shen, PhD | Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Feeds:: Posts; Comments

« System Pharmacology: Using CellMiner and the NCI-60 Cancerous Cell Lines: William Reinhold, PhD

System Pharmacology in a Post-Genomic Era – The Simple Case of Dose-Response: Peter Sorger, PhD »

DNA Methultransferases – Implications to Epigenetic Regulation and Cancer Therapy Targeting: James Shen, PhD

April 22, 2013 by 2012pharmaceutical

Reporter: Aviva Lev-Ari, PhD, RN

Systems Pharmacology – Pathways to Patient Response @ BioIT World, April 9-11, 2013, World Trade Center, Boston, MA

William Reinhold, PhD’s presentation at the conference is to be viewed at the link, below

http://www.chiresource.com/BIT-05-23/Presentations/NPC/Shen_James.pdf

Posted in CANCER BIOLOGY & Innovations in Cancer Therapy, Cell Biology, Signaling & Cell Circuits, Chemical Genetics, Computational Biology/Systems and Bioinformatics, Genome Biology | 3 Comments

3 Responses

on April 22, 2013 at 5:22 PM | Reply larryhbern

This again raises questions in my mind about methyl donor deficiency (methionine) and cancer resistance. Prof. Yves Ingenbleek did not investigate it, but he was not unaware of this. This is perhaps the other side of the coin with veganism.

Loading...
on November 25, 2013 at 4:09 PM | Reply Liver Toxicity halts Clinical Trial of IAP Antagonist for Advanced Solid Tumors | Pharmaceutical Intelligence

[…] DNA Methultransferases – Implications to Epigenetic Regulation and Cancer Therapy Targeting: James… […]

Loading...
on April 20, 2014 at 6:20 PM | Reply Cancer Research: Curations and Reporting: Aviva Lev-Ari, PhD, RN | Pharmaceutical Intelligence

[…] http://pharmaceuticalintelligence.com/2013/04/22/dna-methultransferases-implications-to-epigenetic-r… […]

Loading...

Leave a Reply Cancel reply

Follow Blog via Email

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 2,657 other subscribers

Email Address
Recent Posts
- Artificial Intelligence and Machine Learning (AI/ML) – Enabled Medical Devices September 26, 2021
- NCCN Shares Latest Expert Recommendations for Prostate Cancer in Spanish and Portuguese September 14, 2021
- Standard Operating Procedures for Updating the Map of LPBI India August 24, 2021
- New avenues for research in membrane biology reveals the mobility of protein at work August 23, 2021
- Can the Public Benefit Company Structure Save US Healthcare? August 20, 2021
- Patients with type 2 diabetes may soon receive artificial pancreas and a smartphone app assistance August 13, 2021
- CNS immune interface August 9, 2021
- 3D printing: Improvising the Next-generation Batteries August 8, 2021
- Novartis uses a ‘dimmer switch’ medication to fine-tune gene therapy candidates August 7, 2021
- LPBI Group announces 5th Academic INTERNSHIP as a Verifiable Certificate in Financial Modeling & Econometrics as One Semester or as One Year Program open to Undergraduate and MBA students August 7, 2021
Archives
Archives
Categories
Categories
Meta

%d bloggers like this: